Abstract:BackgroundThe WNT/β-catenin system is an evolutionarily conserved signaling pathway that plays a crucial role in morphogenesis and cell tissue formation during embryogenesis. Although usually suppressed in adulthood, it can be reactivated during organ damage and regeneration. Transient activation of the WNT/β-catenin pathway stimulates tissue regeneration after acute kidney injury, while persistent (uncontrolled) activation can promote the development of chronic kidney disease (CKD). CKD-MBD is a clinical syndrome that develops with systemic mineral and bone metabolism disorders caused by CKD, characterized by abnormal bone mineral metabolism and/or extraosseous calcification, as well as cardiovascular disease associated with CKD, including vascular stiffness and calcification.ObjectiveThis paper aims to comprehensively review the WNT/β-catenin signaling pathway in relation to CKD-MBD, focusing on its components, regulatory molecules, and regulatory mechanisms. Additionally, this review highlights the challenges and opportunities for using small molecular compounds to target the WNT/β-catenin signaling pathway in CKD-MBD therapy.MethodsWe conducted a comprehensive literature review using various scientific databases, including PubMed, Scopus, and Web of Science, to identify relevant articles. We searched for articles that discussed the WNT/β-catenin signaling pathway, CKD-MBD, and their relationship. We also reviewed articles that discussed the components of the WNT/β-catenin signaling pathway, its regulatory molecules, and regulatory mechanisms.ResultsThe WNT/β-catenin signaling pathway plays a crucial role in CKD-MBD by promoting vascular calcification and bone mineral metabolism disorders. The pathway’s components include WNT ligands, Frizzled receptors, and LRP5/6 co-receptors, which initiate downstream signaling cascades leading to the activation of β-catenin. Several regulatory molecules, including GSK-3β, APC, and Axin, modulate β-catenin activation. The WNT/β-catenin signaling pathway also interacts with other signaling pathways, such as the BMP pathway, to regulate CKD-MBD.ConclusionsThe WNT/β-catenin signaling pathway is a potential therapeutic target for CKD-MBD. Small molecular compounds that target the components or regulatory molecules of the pathway may provide a promising approach to treat CKD-MBD. However, more research is needed to identify safe and effective compounds and to determine the optimal dosages and treatment regimens.

Wnt signaling pathway and the pathogenesis of autosomal dominant polycystic kidney disease

Signal Transduction Pathways Involved in the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease

The Advances of Polycystin-1

Advances in autosomal dominant polycystic kidney disease

Autosomal Dominant Polycystic Kidney Disease with Ectopic Unilateral Multicystic Dysplastic Kidney

Mechanistic complement of autosomal dominant polycystic kidney disease: the role of aquaporins

Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease

Clinical Findings, Underlying Pathogenetic Processes and Treatment of Vascular Dysfunction in Autosomal Dominant Polycystic Kidney Disease

Polycystic Kidney Disease: Novel Insights into Polycystin Function.

Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease

Wnt signaling in kidney: the initiator or terminator?

The Wnt Signaling Pathway in Diabetic Nephropathy

Investigating the Dysfunctional Pathogenesis of Wilms' Tumor Through a Multidimensional Integration Strategy.

Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease

Aquaporin‐1 Retards Renal Cyst Development in Polycystic Kidney Disease by Inhibition of Wnt Signaling

Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling

The Genetic and Cellular Basis of Autosomal Dominant Polycystic Kidney Disease-A Primer for Clinicians

Identification of ACOT13 and PTGER2 as novel candidate genes of autosomal dominant polycystic kidney disease through whole exome sequencing

Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies

The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome

Wnt signaling pathway: A comprehensive review